Connective tissue diseases (CTDs) are a group of disorders characterized by abnormal immune system activity affecting the connective tissues throughout the body. These tissues include tendons, ligaments, skin, joints, and organs. Common CTDs include rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. In CTDs, the immune system mistakenly attacks healthy tissues, leading to inflammation and tissue damage. Symptoms vary widely and may involve joint pain, skin rashes, fatigue, and internal organ complications. Treatment aims to manage symptoms and control inflammation, typically utilizing medications such as corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and immunosuppressants. Multidisciplinary care involving rheumatologists, dermatologists, and other specialists is crucial for comprehensive management. Early detection and intervention play a key role in improving outcomes and enhancing the quality of life for individuals affected by connective tissue diseases.
Title : Knotless suture repair for chronic lateral ankle instability: A systematic review & single- arm meta-analysis
Hussein Jaber, University of Cambridge, United Kingdom
Title : The UK profemur recall and implant cobaltism
Stephen S Tower, University of Alaska Anchorage, United States
Title : The tomographic phenotype and the genotype of wormain bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Title : Total Knee Arthroplasty (TKA) in hemophilic arthropathy: Modern outcomes and perioperative strategies
Jack Russek, Touro University California, United States
Title : Musculoskeletal and orthopedic implications of Gender-Affirming Hormone Therapy (GAHT): A PRISMA-Guided systematic narrative review
Jack Russek, Touro University California, United States